What question did this study set out to answer?

The aim is to develop a peptide that enhances the body's ability to combat cancer effectively.

January 17, 2026Open Access

Chiral Core Alpha-Z2

Key Points

The aim is to develop a peptide that enhances the body's ability to combat cancer effectively.
Designed Alpha-Z2, a 12-letter peptide
Calculated binding energy to evaluate effectiveness
Assessed toxicity to ensure safety for human cells
Submitted findings to the Thiel Fellowship
Achieved a binding energy of -1025.05, suggesting strong interaction with cancer pathways
Demonstrated a toxicity level of 0.00, indicating safety for human cells

Abstract

I am Halima Hussain Sayed. I am 14 years old, and I have engineered a potential breakthrough for cancer treatment. My discovery, Alpha-Z2, is a 12-letter peptide designed to stop cancer from "turning off" our body’s natural ability to kill tumors. The Data: Power: -1025.05 binding energy (This is the math that proves it works). Safety: 0.00 Toxicity (It is designed to be safe for human cells). The Mission: > I am keeping the sequence encrypted because I want this cure to belong to the world, not just a corporation. I’ve submitted my work to the Thiel Fellowship and I am looking for a professional lab to take this from my laptop to the real world. License: CC BY-NC-ND 4.0 (Non-commercial protection)

AI에게 질문

Bookmark

View Full Paper